These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27887890)

  • 21. Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.
    Wu SY; Chang HI; Burgess M; McMillan NA
    J Control Release; 2011 Nov; 155(3):418-26. PubMed ID: 21315117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
    Judge A; McClintock K; Phelps JR; Maclachlan I
    Mol Ther; 2006 Feb; 13(2):328-37. PubMed ID: 16275098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple systemic expression of human interferon-beta in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex.
    Meyer O; Schughart K; Pavirani A; Kolbe HV
    Gene Ther; 2000 Sep; 7(18):1606-11. PubMed ID: 11021600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model.
    Kaul G; Amiji M
    J Drug Target; 2004; 12(9-10):585-91. PubMed ID: 15621684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
    Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
    Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
    Lee J; Ahn HJ
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid.
    Boussif O; Gaucheron J; Boulanger C; Santaella C; Kolbe HV; Vierling P
    J Gene Med; 2001; 3(2):109-14. PubMed ID: 11318109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use of Lactose as an Alternative Coating for Nanoparticles.
    Betker JL; Anchordoquy TJ
    J Pharm Sci; 2020 Apr; 109(4):1573-1580. PubMed ID: 32004536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
    Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB
    J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice.
    Hashimoto Y; Abu Lila AS; Shimizu T; Ishida T; Kiwada H
    J Control Release; 2014 Jun; 184():1-8. PubMed ID: 24727075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
    Arangoa MA; Düzgüneş N; Tros de Ilarduya C
    Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system.
    Sakurai F; Nishioka T; Yamashita F; Takakura Y; Hashida M
    Eur J Pharm Biopharm; 2001 Sep; 52(2):165-72. PubMed ID: 11522482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutral postgrafted colloidal particles for gene delivery.
    Thompson B; Mignet N; Hofland H; Lamons D; Seguin J; Nicolazzi C; de la Figuera N; Kuen RL; Meng XY; Scherman D; Bessodes M
    Bioconjug Chem; 2005; 16(3):608-14. PubMed ID: 15898728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
    Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
    J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and release profiles of PEGylated liposomal doxorubicin nanoparticles: A comprehensive picture based on separate determination of encapsulated and total drug concentrations in tissues of tumor-bearing mice.
    Wang H; Zheng M; Gao J; Wang J; Zhang Q; Fawcett JP; He Y; Gu J
    Talanta; 2020 Feb; 208():120358. PubMed ID: 31816795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery.
    Berger M; Toussaint F; Djemaa SB; Laloy J; Pendeville H; Evrard B; Jerôme C; Lechanteur A; Mottet D; Debuigne A; Piel G
    J Control Release; 2023 Sep; 361():87-101. PubMed ID: 37482343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.